Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China
· Delayed Price · Currency is CNY 35.92
+1.59 (4.63%)
Apr 29, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 1,390 | 1,476 | 1,591 | 1,907 | 1,940 | 1,368 | Upgrade
|
| Short-Term Investments | - | - | - | 10 | - | - | Upgrade
|
| Trading Asset Securities | 13.93 | 13.76 | 60.26 | - | 100.06 | 360.84 | Upgrade
|
| Cash & Short-Term Investments | 1,404 | 1,489 | 1,651 | 1,917 | 2,040 | 1,729 | Upgrade
|
| Cash Growth | -13.76% | -9.80% | -13.88% | -6.01% | 18.02% | 561.86% | Upgrade
|
| Accounts Receivable | 86.96 | 89.37 | 97.46 | 61.89 | 38.82 | 146.91 | Upgrade
|
| Other Receivables | 2.18 | 3.44 | 4.27 | 2.8 | 1.6 | 8.32 | Upgrade
|
| Receivables | 89.13 | 92.81 | 101.73 | 64.68 | 40.42 | 155.23 | Upgrade
|
| Inventory | 71.73 | 69.68 | 73.4 | 99.32 | 135.2 | 141.7 | Upgrade
|
| Other Current Assets | 15.94 | 9.59 | 51.57 | 5.37 | 19.6 | 7.2 | Upgrade
|
| Total Current Assets | 1,580 | 1,661 | 1,878 | 2,087 | 2,235 | 2,033 | Upgrade
|
| Property, Plant & Equipment | 534.74 | 540.87 | 408.81 | 261.58 | 244.68 | 231.02 | Upgrade
|
| Long-Term Investments | 60.53 | 31.41 | 19.3 | 2.84 | 40 | 40 | Upgrade
|
| Other Intangible Assets | 267.89 | 269.31 | 275.16 | 208.71 | 213.71 | 20.35 | Upgrade
|
| Long-Term Deferred Tax Assets | 13.99 | 10.1 | 11.8 | 14.44 | 13.16 | 3.01 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 0.11 | 0.21 | 0.29 | Upgrade
|
| Other Long-Term Assets | 28.51 | 26.25 | 9.15 | 5.08 | 4.54 | 104.13 | Upgrade
|
| Total Assets | 2,486 | 2,539 | 2,602 | 2,580 | 2,752 | 2,432 | Upgrade
|
| Accounts Payable | 65.47 | 98.67 | 56.45 | 58.35 | 88.72 | 224.32 | Upgrade
|
| Accrued Expenses | 6.6 | 15.55 | 19.08 | 20.02 | 25.94 | 26.32 | Upgrade
|
| Short-Term Debt | 0.44 | 0.49 | 0.44 | 0.59 | 0.35 | 5.64 | Upgrade
|
| Current Portion of Leases | - | - | - | 2.45 | 5.1 | 2.28 | Upgrade
|
| Current Income Taxes Payable | 1.78 | 3.73 | 0.02 | - | - | 39 | Upgrade
|
| Current Unearned Revenue | 11.74 | 15.16 | 7.39 | 47.16 | 44.68 | 18.56 | Upgrade
|
| Other Current Liabilities | 25.95 | 24.38 | 95.23 | 20.85 | 6.28 | 1.44 | Upgrade
|
| Total Current Liabilities | 111.98 | 157.98 | 178.62 | 149.43 | 171.08 | 317.56 | Upgrade
|
| Long-Term Leases | - | - | - | - | 2.19 | 4.55 | Upgrade
|
| Long-Term Unearned Revenue | 9.75 | 10.19 | 11.17 | 8.69 | 6.43 | 1.25 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 0.71 | 1.16 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 8.43 | - | Upgrade
|
| Total Liabilities | 121.73 | 168.17 | 189.79 | 158.82 | 189.29 | 323.36 | Upgrade
|
| Common Stock | 149.33 | 149.33 | 106.67 | 106.67 | 106.67 | 106.67 | Upgrade
|
| Additional Paid-In Capital | 752.28 | 751.68 | 790.45 | 813.33 | 814.94 | 814.94 | Upgrade
|
| Retained Earnings | 1,475 | 1,486 | 1,543 | 1,510 | 1,638 | 1,185 | Upgrade
|
| Treasury Stock | -18.07 | -18.07 | -31.61 | -14.76 | - | - | Upgrade
|
| Comprehensive Income & Other | 1.54 | 1.24 | 0.94 | -0.36 | 1.21 | 0.7 | Upgrade
|
| Total Common Equity | 2,360 | 2,370 | 2,409 | 2,415 | 2,561 | 2,107 | Upgrade
|
| Minority Interest | 3.78 | 1.47 | 2.87 | 5.51 | 1.04 | 1.05 | Upgrade
|
| Shareholders' Equity | 2,364 | 2,371 | 2,412 | 2,421 | 2,562 | 2,108 | Upgrade
|
| Total Liabilities & Equity | 2,486 | 2,539 | 2,602 | 2,580 | 2,752 | 2,432 | Upgrade
|
| Total Debt | 0.44 | 0.49 | 0.44 | 3.04 | 7.64 | 12.47 | Upgrade
|
| Net Cash (Debt) | 1,403 | 1,489 | 1,651 | 1,914 | 2,032 | 1,716 | Upgrade
|
| Net Cash Growth | -13.73% | -9.80% | -13.77% | -5.81% | 18.43% | 586.22% | Upgrade
|
| Net Cash Per Share | 9.68 | 10.28 | 11.20 | 12.83 | 13.60 | 14.15 | Upgrade
|
| Filing Date Shares Outstanding | 145.83 | 102.38 | 148.78 | 146.38 | 149.33 | 149.33 | Upgrade
|
| Total Common Shares Outstanding | 145.83 | 102.38 | 148.78 | 148.7 | 149.33 | 149.33 | Upgrade
|
| Working Capital | 1,468 | 1,504 | 1,699 | 1,937 | 2,064 | 1,715 | Upgrade
|
| Book Value Per Share | 16.19 | 23.15 | 16.20 | 16.24 | 17.15 | 14.11 | Upgrade
|
| Tangible Book Value | 2,093 | 2,100 | 2,134 | 2,207 | 2,348 | 2,087 | Upgrade
|
| Tangible Book Value Per Share | 14.35 | 20.52 | 14.35 | 14.84 | 15.72 | 13.97 | Upgrade
|
| Buildings | - | - | 306.67 | 193.65 | 194.71 | 189.13 | Upgrade
|
| Machinery | - | - | 96.17 | 90.92 | 81.61 | 66.19 | Upgrade
|
| Construction In Progress | - | - | 87.23 | 39.65 | 9.85 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.